Archive for January, 2012

Actos Bladder Cancer Legal Bulletin

Actos Bladder Cancer : Within treatment trials, there are four categories, or phases. You’ll want to ask the members of your medical team which phase of clinical trial they are recommending to you and find out specific details such as the number of people involved, where the testing is being done, what benefits/drawbacks are expected for you personally, and how long the trial is expected to last.

Phase I trials study how to administer a new drug or treatment and how much of the drug or treatment can be safely tolerated. The drugs or treatment in a Phase I trial have been extensively tested in a lab and in animal studies, but not in humans. If a drug is being tested, researchers may start by giving a very low dose of the drug to those participating in the trial, then increase it gradually to determine when side effects appear and what dosage is tolerable, yet effective. Phase I trials usually enroll a small number of people at a limited number of locations. In general, they are the least likely to be of direct personal benefit to a patient, as the drugs are less well known, but occasionally they can lead to significant tumor shrinkage with side effects well within the tolerable range.

Phase II trials take the studies a step further. From the Phase I results, researchers know what dosage to give with a good margin of safely – now they are ready to test whether the drug really works as well as anticipated. They carefully monitor patients in the study for side effects and observe closely how the drug affects the cancer. A Phase II study usually targets a particular disease or type of cancer and includes fewer than 100 people.

Phase III trials involve large groups of people across a broad geographical area. A random process determines which individuals will receive the drug being tested and which ones will receive standard treatment. The idea is to compare accurately whether the new treatment is better than the old treatment and whether there are different patterns of side effects and survival. The results are monitored closely, and if one treatment is observed to be significantly more effective than the other, the trial is stopped. Sometimes a phase III trial will show that the new treatment actually is not better than the standard, in which case the new treatment is usually “dropped” from our list. The reason to “randomize” the study, choosing patients randomly for the new and standard treatments, is to avoid introducing biases into the study. For example, without randomization, there might be an inadvertent tendency to choose the younger and stronger patients for the new agent and older patients with other medical problems for the established treatment.This might make the new treatment appear to be better than the established treatment when, in fact, the differences were due only to the type of patient receiving each type of treatment.

More information on Actos Bladder Cancer

End-of-life decisions are difficult, painful, and heartbreaking. They raise issues we don’t want to face, either for ourselves or with someone we love. Yet at times, despite aggressive and thorough care, there are no further drugs or therapies or surgeries or clinical trials with curative possibilities, and the only option one’s medical team has is to recommend hospice care.

The goal of hospice care is not to cure disease; its goal is to provide palliative care – comfort, pain relief, and support – for those facing end-of-life choices. Hospice care addresses quality of life. It involves a team approach similar to the medical team model. Hospice providers offer palliative care specific to those facing an end-of-life diagnosis and their families.

Hospice care doesn’t mean that one won’t take any more medications or that there may not be some continuing therapies to help with symptoms and quality of life. In the case of advanced bladder cancer, it means that one’s medical team has determined that further medical strategies are not likely to cure one’s bladder cancer and are not likely to prolong life. Death is the likely outcome, and the emphasis of treatment will change to focus on control of symptoms. Death. It’s such a hard word. Such a scary concept. The questions pile up in one’s mind. Will there be a lot of pain or indignity? What about being physically able to enjoy the rest of life? How to take care of the overwhelming, ongoing business of life?

Information from other sources on Actos Bladder Cancer

A new or persistent pain, whether a nagging backache or a shooting pain, can signal that one’s cancer has changed or grown in some way. Doctors depend on patients to describe any pain, however intermittent or insignificant, so that they can better treat not only the disease, but any affiliated pain as well. For example, a tender, aching pain in the upper back or shoulder may indicate that cancer has moved into the chest cavity or bones. One might feel a squeezing cramp in the abdomen or a shooting pain that feels like an electrical current. However, it is also important to remember that the presence of a new pain doesn’t necessarily mean that cancer is active at that site, as pain can be due to many other factors, such as infection or inflammation.

Each of these types of pain tells doctors something different and requires a different combination of drugs and therapies to help them minimize discomfort while they’re managing the progression of the disease. Some people resist telling their doctor about pain because they think that “pain management” involves using drugs such as morphine that leave one pain-free but occasionally in a drowsy fog, and they don’t want to spend their days “doped up.” Some people simply fear the possibility of addiction, even if they are dying.

Because of the many options available today for pain control, these problems usually don’t occur, although the first few days of pain medication (before the optimal dose is found) may be associated with some drowsiness or nausea. There may be circumstances when narcotic drugs such as morphine are the best option for pain relief. But usually doctors can put together a combination of non-narcotic anti-inflammatory or nonsteroidal anti-inflammatory drugs (such as ibuprofen) that will do the trick while leaving patients alert and able to participate in some of the things they love to do, whether sewing or baking apple pie or even golfing.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Actos Bladder Cancer Legal Update

Actos Bladder Cancer : Chemotherapy is offered most often in the face of metastatic disease or advanced local disease that cannot be removed surgically. Chemotherapy in this setting can result in complete response (disappearance of all visible tumors) in approximately 20% of patients. For these individuals, success of therapy can be monitored with imaging studies such as CT scans. Despite initial improvement, long term survival is rare.

Neoadjuvant therapy, therapy given prior to cystectomy, has several advantages. Chemotherapy is given to the patient prior to surgery when the person is strongest. Tumors can be reduced in size potentially making surgery easier when dealing with larger cancers. Earlier treatment of micro-metastatic disease may offer improved results. Most studies have demonstrated the regimens to be well tolerated and do not increase surgical complications afterwards. The downside is the delay of surgery by approximately three months which can be critical for patients whose chemotherapy is ineffective.

In addition, one must face the toxicities of this therapy which may affect the individual’s overall state of health prior to surgery. Since the true pathologic stage is unknown, many patients with organ confined disease may receive chemotherapy unnecessarily. Many oncologists reserve neoadjuvant therapy for those with disease beyond the bladder (Stage T3 or T4). Some studies have shown a reduction in mortality, while others have not. One recent article which reviewed multiple studies using neoadjuvant cisplatin based combination therapy showed a 6.5% improved survival at 5 years.

The most common regimen consists of using four different drugs MVAC (methotrexate, vinblastine, adriamycin and cisplatin) given in a 21 or 28 day cycle. During each cycle, different chemotherapy drugs are given on different days to afford maximal cancer killing effect and minimizing side effects. Generally, two cycles are given prior to assessing effectiveness and proceeding with further chemotherapy.

More information on Actos Bladder Cancer

Historically, the most effective drug regimen and the standard of care is MVAC. This combination of drugs is more effective than any drug alone. The drug regimen consists of methotrexate, vinblastine, adriamycin, and cisplatin. This regimen is difficult to tolerate. Side effects and toxicities include nausea, diarrhea, bone marrow suppression (resulting in anemia and a drop in the white blood cells, which fight infection, a drop in platelets, which help in clotting, mouth ulcers, the possibility of kidney and heart damage, and nerve impairment resulting in numbness). Because of the decline in the immune system as a result of this regimen, serious infection leading to death occurs in approximately 3% of patients. Given the serious side effects and potential for the possibility of life threatening complications, only an experienced oncologist should supervise this therapy. By careful monitoring and the use of medications to control side effects, the therapy can be made safer and easier to tolerate.

For the elderly or those individuals not in the best of health, gemcitabine combined with cisplatin (GC) have become an effective, but less toxic combination. This therapy was not originally believed to be as effective as MVAC, but is more tolerable and does not have the higher risk of serious secondary infections developing. A recent randomized trial compared MVAC with GC. In this study of 405 patients, an overall response of approximately 50% was seen with either regimen, with substantially lower toxicity with GC. Although the study cannot predict overall differences in survival, the similar response rate with reduction in toxicity has now made GC first line therapy for an increasing number of oncologists.

Information from other sources on Actos Bladder Cancer

The answer to this question must always be an individual one. It is best answered after considering the potential gain versus the potential side effccts and risks. Initial side effects experienced by almost all individuals will include nausea and vomiting, diarrhea, mouth ulcers, extreme fatigue, loss of appetite and weight loss, hair loss, and a drop in blood counts. Many of the side effects can be lessened by taking appropriate medication. Long term side effects include low blood count, nerve and kidney damage. Side effects can be severe and potentially life threatening. Death as the result of sepsis from MVAC treatment occurs in approximately 3% of patients.

Even if side effects are not severe, chemotherapy may result in the individual rapidly becoming weak and tired, reducing markedly his quality of life. The side effects for the most part are not long lasting with a return to normalcy after chemotherapy has been completed. If you are not tolerating the chemotherapy regimen well, your oncologist can modify the dose, frequency of dosing, or alter the regimen entirely.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Actos Bladder Cancer Message

Actos Bladder Cancer :  In Europe, chemotherapy drugs like mitomycin C, doxorubicin, epirubicin, and valrubicin are commonly used as first-line intravesical therapy. These agents are not considered first line in the United States because several studies have shown improved effectiveness with BCG compared to these drugs. Furthermore, unlike BCG, which decreases the risk of cancer progression to muscle invasion, these agents have never been definitively proven to have any effect on tumor progression. They are currendy considered second-line agents for patients who cannot tolerate, have a contradiction to, or fail BCG therapy. The exception to this is the use of mitomycin C as a single instillation immediately after TURBT, which has been shown to decrease the risk of bladder tumor recurrence in up to 40 percent of cases.

Intravesical therapy is performed on an outpatient basis and is generally well tolerated. Common side effects during therapy include irritative voiding symptoms like painful urination, frequency, and urgency during treatment. Each intravesical agenthas its own side effects, anditis important that you discuss this with your physician before treatment.

Systemic chemotherapy is an important part of the treatment plan for many patients with muscle-invasive and locally advanced bladder cancer. The first-line chemotherapeutic agent used for the treatment of bladder cancer is Platinol (cisplatin). Cisplatin is used most commonly in combination with other chemotherapy drugs because it has been found that the combination of medications is more effective than any single agent alone. The two most common combinations are methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) or gemcitabine and cisplatin. MVAC is an older and more extensively studied regimen, but gemcitabine-cisplatin has shown equivalent effectiveness to MVAC with fewer side effects, making it the preferred choice of many medical oncologists today. One important prerequisite to cisplatin treatment is normal kidney function. If your kidney function is impaired, your medical oncologist will likely choose other second-line chemotherapy drugs that will be less toxic to your kidneys.

More information on Actos Bladder Cancer

Chemotherapy for bladder cancer is administered either before surgery (neoadjuvant chemotherapy) or after surgery (adjuvant chemotherapy). No study has direcdy compared the effectiveness of one approach over the other, and each approach has its advantages and disadvantages. Neoadjuvant chemotherapy offers the advantage of reducing the tumor volume before surgery, which may decrease the chance of having a positive surgical margin at the time of surgery. Because it is administered early (before surgery), it has the benefit of treating the cancer at a potentially earlier stage when the burden of metastatic disease is small.

Finally, because surgeiy requires a significant amount of healing time, patients may be more “fit” for the rigors of chemotherapy before surgeiy. Several well-designed, prospective, randomized trials have demonstrated an improved survival in bladder cancer patients who undergo neoadjuvant chemotherapy. Neoadjuvant chemotherapy does have two main disadvantages. First, because our current clinical staging systems are not 100 percent accurate, a significant percentage of patients who may not need chemotherapy will be treated and subjected to its side effects. Second, upfront administration of chemotherapy may delay cystectomy in patients who do not respond to chemotherapy.

Adjuvant chemotherapy is administered after radical cystectomy. Giving chemotherapy after surgery offers the advantages of administration only to those patients who absolutely need it, and there is no delay in surgery, which minimizes risk of disease progression. The main disadvantage of adjuvant chemotherapy is a potential delay in chemotherapy for patients who need it while they are recovering from major surgery. Adjuvant chemotherapy has been less well studied than neoadjuvant chemotherapy, but studies have demonstrated its effectiveness in patients with locally advanced and lymph node-positive bladder cancer.

Information from other sources on Actos Bladder Cancer

Radiation therapy is most commonly used in combination with other treatment methods (chemotherapy and TURBT) in bladder-sparing protocols. There is little evidence to suggest that primary radiation therapy as a single agent is effective in treating non-muscle-invasive bladder cancer. Though radiation therapy is moderately effective as a primary treatment for muscle-invasive bladder cancer, 50 percent of patients treated in this manner will eventually develop metastatic disease. Additionally, many patients treated only with radiation will ultimately require a salvage cystectomy for local recurrence. External beam radiation as a sole treatment method is not currently considered adequate treatment in the United States.

Bladder preservation requires an integrated and cooperative approach from the patient, urologist, radiation oncologist, and medical oncologist. To achieve optimal success, individuals who are unlikely to respond to this therapy should be excluded, including those with evidence of cancer extending through the bladder wall (stage T3). Individuals who do not respond during the initial chemoradiation period are encouraged to undergo cystectomy. This is an important component of this approach, because those who do not respond early to bladder preservation may still be salvaged with early conversion to cystectomy. In highly selected patients, trimodal therapy has shown similar overall survival rates compared with radical cystectomy.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Mesothelioma Cancer Notification

Mesothelioma Cancer : After performing the physical exam and taking a his­tory that concentrates on whether you have developed shortness of breath or pain, the doctor will order a chest x-ray. Based on what is found, the doctor will determine what other tests you will need. The doctor may also order blood work. When a tumor or fluid is found, the doctor will need to perform a procedure that mil obtain cells for the physicians to study to determine whether this is a cancer or not. This can be done by performing a biopsy of the mass or by tapping fluid (inserting a needle and drawing out fluid) from the chest or belly cavity and then analyzing the cells that come with the fluid. The analysis of cells from fluid is called cytology. Although an x-ray or scan may provide useful information about the size, shape, and location of a tumor or fluid and may alert your doctor to the possibility of a cancer, an actual diagnosis of mesothelioma cannot be made without a biopsy, or undeniable evidence of cells in the fluid that have the characteristics of a mesothelioma. Mesothelioma Cancer

For more information on Mesothelioma Cancer follow us on our RSS Feeds.

There are no specific blood tests that can tell your doctor you have mesothelioma. Certain blood cell values may be abnormal when a patient has mesothelioma, but these are nonspecific (that is, they do not definitively tell the doctor that it is mesothelioma or another type of cancer or a benign condition). The white blood cell count (cells that fight infection) may be elevated and/or the platelet count (cells that help the clotting system) maybe elevated above normal values.

The liquid part of blood (serum) is partially comprised of dissolved proteins. Currendy, there are no specific proteins in the serum that can tell your doctor you have asbestosis or mesothelioma. Proteins that are spe­cific to a certain disease are called biomarkers. There is great interest in the discovery of these biomarkers, which may represent unique proteins from the tumor that appear early in the disease and increase as the dis­ease progresses. Ask your physician whether any of these markers are under study or whether any have been approved by the FDA for the study of mesothe­lioma. These markers include soluble mesothelin related protein (SMRP) and osteopontin. Mesothelioma Cancer

Information from other sources on Mesothelioma Cancer

The results of the chest x-ray will usually prompt the doctor to order a CAT or CT scan (computerized axial tomography scan) of the chest and abdomen. These scans provide a three-dimensional view of the area of the body that the physician is interested in. CT scans have a better ability to show how much solid mass is present and how much fluid contributes to the picture. They also give a much better anatomic picture so your doctor can see how any masses relate to the lung, heart, diaphragm (the muscle that helps you breathe), and blood vessels in the chest or abdomen. CT scans do not tell the doctor what type of tumor it is or whether the disease has invaded other structures, but they do give a very good idea of whether your disease can be classified as early with minimal disease (Stage I), later with moderate amount of disease (Stage II), or advanced with a large amount of disease (Stages III and IV). (We will discuss the concept of staging in more detail later on.) In mesothelioma, a CT scan is not very good for showing whether your lymph nodes (the round structures in certain positions in the chest and abdomen that drain the lung and intestines and act as filters and sites for immune responses) are involved. The reason it does not show this well is that the pleura can be thickened in areas where the lymph nodes are, and this lumpy, bumpy thickening can be confused with lymph nodes or can hide lymph nodes.

Our use of the term or terms Mesothelioma Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Cancer visit our site often.

Mesothelioma Cancer

Mesothelioma Cancer Report

Mesothelioma Cancer : The doctor may also request an MRI (magnetic reso­nance image). An MRI uses radio waves and strong magnets along with a computer to form detailed images of the body. The MRI can occasionally give the doctor information about whether the diaphragm or chest wall have become involved and if the tumor has invaded through it. Not all mesothelioma specialists use MRIs in their workup. A PET scan (positron emission tomography scan) is a relatively new type of scan that shows how the body takes up and uses glucose (sugar). Tumors, cancer cells, and areas that are inflamed or infected use glucose at a higher rate than normal tissues do. Since a radioactive tracer is attached to the glucose injected into your body, the areas which use glucose at a higher rate (i.e. tumors) will hold onto the radioactive tracer longer than normal cells. Areas on PET scans that “light up” as bright spots are abnormal. It is important to know, however, that abnormal areas on PET scans are not necessarily cancerous; they can also be the result of inflammation. The PET scan can also give the doctor information as to whether the cancer has spread outside the original area to other parts of the body, and it may pick up areas of spread that are completely unexpected. Mesothelioma Cancer

For more information on Mesothelioma Cancer follow us on our RSS Feeds.

There have not been enough large studies that prove the usefulness of this scan in mesothelioma, and therefore it has not been approved by most insurance companies as a standard test for mesothelioma, as it has been for lung cancer. However, there are mechanisms that can help pay for PET scans that doctors who do them (nuclear medicine physicians) can help you with. Ask them about these programs. A patient with a large, unexplained fluid accumulation in the chest or abdomen and who has a small or moder­ate amount of thickening of the pleura should have a biopsy performed, using semi-invasive techniques (tech­niques that require only local anesthesia and that do not involve cutting into the chest or abdomen). For exam­ple, the biopsy might involve an initial thoracentesis (drainage of fluid in the chest) or paracentesis (drainage of fluid in the abdomen) and a pleural biopsy. These are relatively safe procedures that can be performed by a pulmonologist (lung physician), a radiologist, or a sur­geon. A local anesthetic (a numbing medicine such as lidocaine) is given to temporarily reduce the feeling in the area before the needle is inserted. Mesothelioma Cancer

Information from other sources on Mesothelioma Cancer

A pleural biopsy with a special needle may help in get­ting a diagnosis of mesothelioma, and it is generally performed by a pulmonologist. Since mesothelioma is usually diffuse (widely scattered) in the chest, a ran­dom sample of the pleura may give tissue with mesothelioma cells in it. A thoracentesis can be performed after the pleural biopsy is completed. The doctor inserts a needle into the pocket of fluid in the chest or abdomen to draw off some of the fluid. Many times, the needle is simply used to insert a flexible catheter (a tube the size of thin spaghetti) which is then used to draw off the fluid. After the fluid is drawn out through this catheter, the catheter is removed.

Our use of the term or terms Mesothelioma Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Cancer visit our site often.

Mesothelioma Cancer

Mesothelioma Lawyers Release

Mesothelioma Lawyers : The fluid and the tissue from the pleural biopsy will be sent to a pathologist and/or cytologist who will look under the microscope at the cells and determine whether mesothelioma is present. In the past, a diag­nosis of mesothelioma from fluid alone was possible only a third of the time because of the difficulty of distinguishing between reactive or noncancerous cells and tumor cells. By staining the fluid with a special substance, pathologists can now make a diagnosis more easily. Your doctor will refer to these stains as “immunos,” short for immunohistochemistry. You should make sure that any material used in the biopsy has been studied using these immuno stains. A chest x-ray is always performed after these procedures to make sure there were no complications from the biopsies, such as an accumulation of air in the chest (pneumothorax). The chest x-ray is also very important to see whether the majority of the fluid has been removed and if the lung is now able to expand with air and fill the chest cavity as it normally should. Mesothelioma Lawyers

For more information on Mesothelioma Lawyers follow us on our RSS Feeds.

More-invasive testing may be needed if the initial results of the semi-invasive tests do not provide ade­quate information or if the CT scan indicates that it would be difficult to do the semi-invasive tests. The latter situation would occur if the fluid is not free flow­ing but is hidden in pockets that are difficult to reach. In such cases, it is better to inspect the chest directly to find out where to do the biopsy. A thoracoscopy (the use of a lighted scope, with or without a camera, to look into the chest) is performed in patients who are at risk for mesothelioma and who develop a large fluid accumulation, with or without associated solid tumor masses in the chest. In patients who are at risk for mesothelioma but whose thoracentesis does not reveal cancer cells, or who experience a recurrence of fluid after the initial thoracentesis is performed, a thora­coscopy should probably be performed. This procedure involves using a special lighted instrument called a thoracoscope to look inside the chest cavity. The scope is placed into the chest between two ribs after a small (1-inch) cut is made through the chest wall. If the doctor finds any tissue that looks abnormal, he or she will cut out a piece, or biopsy a piece, of it to have it looked at under the microscope. This tissue will then be examined for cancer cells. Mesothelioma Lawyers

Information from other sources on Mesothelioma Lawyers

Lastly, if the radiologic tests indicate that there is more solid tumor than fluid, or if there is no longer a space where fluid can accumulate because of previous attempts to control the fluid, an “open” biopsy may be indicated. The incision does not have to be large if the pleura is thickened, but the procedure should be per­formed by a thoracic surgeon who understands the principles of mesothelioma treatment. This surgeon will usually suggest a 3- or 4-inch incision on the side of the chest, overlying an area of pleura that is thickened. The surgeon may or may not remove a small piece of rib at this site to allow a direct view of the thickened pleura. Many times, a good-sized piece of pleura (1 to 1 1/2 inches in diameter) can be removed at this site. Getting a quick freeze of the tis­sue in the operating room, with the pathologist look­ing at the biopsy, will ensure that there’s enough tissue to perform all the required testing and to make a diagnosis. Surgeons performing these biopsies should pick the right place for the biopsy, and the cut (inci­sion) for this biopsy should be in line with the longer incision that would be used later if the patient is a surgical candidate. That way, this shorter incision can be removed.

Our use of the term or terms Mesothelioma Lawyers is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Lawyers visit our site often.

Mesothelioma Lawyers

Vaginal Mesh Lawsuit News

Vaginal Mesh Lawsuit News (01/25/2012): Amid concern over the serious side effects associated with vaginal mesh, the U.S. Food and Drug Administration released a Public Health Notification citing numerous complications with placement of surgical vaginal mesh in repair of pelvic organ prolapse and stress urinary incontinence. A Vaginal Mesh Lawsuit could be an option for women suffering from injuries of vaginal mesh. Some of the most frequent complications include erosion, infection, urinary problems, pain and bowel, bladder and blood vessel perforation during insertion. To learn how you may be able to recover damages for your vaginal mesh injuries, you are urged to locate a Vaginal Mesh Lawsuit attorney. Best Legal Source can put you in touch with an experienced Vaginal Mesh Lawsuit attorney who will discuss the feasibility of filing a Vaginal Mesh Lawsuit. Call us today at 800-611-7080 or complete the form to the right.

1-800-611-7080

In some cases, vaginal scarring can lead to considerable decrease in a patient’s quality of life. Moreover, other side effects could necessitate additional surgical procedures. If you or a loved one has been injured by a defective vaginal mesh implant, you may be entitled to financial compensation by filing a Vaginal Mesh Lawsuit. It is the mission of Best Legal Source to help injured parties locate a law firm willing to file a Vaginal Mesh Lawsuit.

The use of the terms Vaginal Mesh Lawsuit, Vaginal Mesh Lawsuit attorney, or any other phrase containing the words Vaginal Mesh, does not imply any connection between Best Legal Source and the manufacturers of vaginal mesh. Vaginal Mesh Lawsuit is used for descriptive purposes only. It explains the legal process and service provided by an attorney experienced in a Vaginal Mesh Lawsuit and other similar cases.

Vaginal Mesh Lawsuit attorneys are providing consultations and claim evaluations for women who have suffered from complications of vaginal mesh. However, these lawsuits have a limited amount of time to be filed. Call Best Legal Source today and be connected with a knowledgeable Vaginal Mesh Lawsuit attorney who will discuss with you the possibility of filing a Vaginal Mesh Lawsuit. Take that first step.

1-800-611-7080

 

Vaginal Mesh Lawsuit: More Information about Your Search

Vaginal Mesh Lawsuit News – 1/30/2012: It is generally agreed that the woman should In* part of any decision-making process and that her views and choice must be taken into account. There is evidence that where women are part of the decision-making process, a successful outcome and psychological well-being are more likely to occur. Now that women are having fewer babies and the chance of dying in childbirth is low, how much choice should women have in the mode of their delivery? The ideal f or most women would be an uneventful pregnancy, labor and a normal vaginal delivery. This is more likely to be achieved for the woman who has spontaneous onset of labor, 110 interventions and one-to-one support. However, even for a woman without any factors indicating an increased risk for a problem, there is no guarantee that the ideal will be attained. Risk selection during pregnancy may predict a lower risk during delivery, but major risks (placental abruption or the need for emergency caesarean section) cannot be reduced to zero.

The stereotype of older people in general is too often a negative one and older women may be treated especially badly. As a result, the low income and lack of support experienced by many older women can contribute directly to physical and psychological ill health.33 Womens health status will also vary with their economic and social status. Despite the existence of the National Health Service (NHS), a British woman in social class 1 or 11 still has almost four years greater life expectancy than her compatriot in social class IV or V. She will also have significantly less chance of dying during pregnancy or childbirth.’”*4 Of the 70 major causes of death in women, 64 are more common in those married to men in unskilled or semi-skilled occupations, with breast cancer being the only major exception.” These differences are also reflected in patterns of morbidity, with 15 per cent of professional women reporting limiting and long-standing illness compared with 31 per cent of women in unskilled occupations.n Figures from Australia show a similar pattern. In 1995, 22 per cent of those adults (15+) living in the most disadvantaged areas rated their health as only fair or poor compared with only 12 per cent in the least disadvantaged areas.

Race and ethnicity also affect health status in a variety of ways. Racist and discriminatory practices are one element in the structural disadvantage that members of many ethnic minority communities still experience. Different cultural beliefs, demographic structures and levels of access to a range of economic and social resources also contribute to the variations in patterns of health and illness found between ethnic groups. As yet there have been few attempts to explore the influence of gender on these complex processes but some interesting findings are now begin­ning to emerge. In the UK, for instance, there is growing evidence of the mental health problems facing young women of South Asian background who have to develop their identity against what are often very conflicting demands and expectations.

A number of Australian studies have also highlighted the importance of respecting cultural preferences in the design and delivery of services. A recent study of Islamic women in Melbourne found that while they valued the quality of care they were given, they still expressed dissatisfaction with some aspects of it.51 They reported that cultural differences often made communication difficult and many made clear their preferences for women doctors. In the sphere of prevention, a study in Brisbane identified significant cultural barriers to cervical and breast .screening among Thai women which needed to be tackled if the services were to be equitably distributed

These issues have generated particular concern in die context of reproductive health care where the price paid for access to technology can be loss of autonomy.53-55 Women seeking to use modern methods of fertility control may need to negotiate with a doctor whose personal judgements about the appropriateness of particular methods may constrain the womans own choice. This appears to be especially true of some younger women.In surgery too, women are sometimes denied the opportunity to participate fully in treatment decisions. In the case of breast cancer surgery and hysterectomy in particular, many still report lack of support in their attempts to make an informed choice.

Vaginal Mesh Lawsuit: Additional Information and Resources

Vaginal Mesh Lawsuit: Respecting women’s right to make decisions about their health care is one part of respecting autonomy, but we also need to look beyond the consultation to a wider understanding of the relationship between women and health care. Who decides which treatments are to be offered, or even which conditions count as diseases? For example, women with fertility problems have little option but to remain childless or to seek technical medical interventions as other solutions, such as adoption, are not easily available. The range of treatments offered in the consultation has been shaped by previous professional interests and research funding, and may not repre­sent anything like an ideal set of choices.

Beneficence is an important ethical consideration when patients cannot discuss their own preferences, for example if they are unconscious or too ill to talk. In these situations the IICP should talk to family or others who know the woman, check whether she has made an Advance Health Directive or appointed someone to have enduring power of attorney for health, and try to understand what the person would want for herself. Other people may be better equipped than the HGP to advise a woman in these situations. Beneficence can slip over into paternalism when HCPs ignore the preferences of women who are able to make their own decisions, and instead make decisions based solely upon the HCPs view about what is best for this person.

Access to health care raises issues of justice are resources distributed fairly in the community and do they reach those who need them most? Much ill health reflects socio-economic inequalities and yet it is often the poorest communities which have the least access to health care. Sometimes there is a tension between doing the greatest good for the greatest number and making health inequalities worse. Screening programs and lifestyle interventions tend to have the least health impact upon the most deprived sections of society while improving the health of others who are better off. Expensive technological interventions may divert resources away from basic health care in other areas. For any intervention, it is worth asking what the impact is upon deprived or marginalized groups. At the same time, advances in science and medicine have the potential to increase knowledge and patient choice.

Vaginal Mesh Lawsuit : More Research for you Query

Vaginal Mesh Lawsuit News: Women may seek either to avoid pregnancy or to become pregnant. Unless women have access to safe, reliable contraception, their opportunities for having control over other aspects of their life such as employment and relationships are limited. Not all women have access to contraceptive services or can find a method which suits them; some may disagree with the use of contraception. Should the right to control fertility extend to abortion? One of the arguments in support of open access to abortions is that there are harmful consequences for women if they are forced to continue unwanted pregnancies. Without the freedom to end pregnancies, women may damage their health, be unable to care for existing children and have their opportunities in life reduced. For women who suffer failures of contraception or who are forced to have sex, abortion offers a way to avoid unplanned consequences. However, people who believe that performing an abortion is equivalent to killing a person are strongly opposed to abortion, even if the womans health and other interests are at risk.

New technologies raise new ethical dilemmas. Reproductive technologies are no exception, from extracorporeal fertilization to genetic manipulation of fertilised embryos and the non-reproductive use of spare embryos. Is infertility a natural misfortune? Does our culture put pressure on women to undergo risky and often unsuccessful medical treatment for the ‘disease’ of infertility, or is the restriction of access to fertility treatments an unfair restriction on women’s choices? The risks and benefits to the individual can be considerable: the chance of a healthy baby versus the increased risks of ectopic pregnancy and multiple births, the stress and anxiety generated, and the costs involved. Should access to reproductive technologies be restricted to socially approved women, excluding those who do not fit into traditional family patterns?7” Many people feel that having children is a fundamental part of human life, and that it is wrong to deny people the chance to try for a family. Using reproductive technologies may avoid harms such as some genetic diseases, or allow parents greater choice about the children they have—should this extend to choice of gender or other attributes such as hair or eye color? Where does this lead?

Despite evidence about the prevalence of depression, rates of detection and treat­ment are suboptimal, due at least in part to the attitudes and training of health professionals. The attitudes of women themselves may compound the problem, particularly if they are reticent about expressing the full nature of their emotional concerns. For example, less than half of a group of clinically depressed women attending an outpatient gynecology clinic identified themselves as having depression, although the majority were prepared to acknowledge that they were ‘distressed’.4*’ Shame and guilt about being depressed may make the woman reluctant to seek help, and in some contexts such as in the postpartum period, the sense of being unworthy as a mother may lead to secrecy about the re til level of emotional distress.

Many doctors feel they are able to tell the kind of bladder problem you are having based upon your answers to the questions and the examination in the office. However, a recent study found this ap­proach to diagnosis much less than 100 percent accurate. The re­searchers asked a bladder specialist to look at the records of more than three hundred women who had bladder problems, with the exception of the results of urodynamic tests that were also per­formed. The specialist diagnosed one hundred women with stress incontinence based on answers to the doctor’s questions and phys­ical examination. But a careful look at the urodynamics testing showed that only thirty-eight of those women really had pure stress incontinence. The other women had either an overactive bladder or a mixture of stress incontinence and an overactive bladder.

Vaginal Mesh Lawsuit: More News and related Information

Vaginal Mesh Lawsuit News: Urodynamics testing tells us about the pressures inside the blad­der and urethra, but it does not tell us what the bladder and urethra look like when the bladder is filling or emptying. Some research centers have been testing video urodynamics equipment, which al­lows the physician to see the bladder on X ray as it fills, holds fluid and empties. By comparing this X-ray picture with the actual pres­sures recorded at the same time by the urodynamics instruments, they can get a good picture of how the bladder is actually working. If the flow of urine out of the urethra is blocked, the video re­veals where the blockage is. If the bladder and urethra are not working properly to let the urine out, the video may show the ure­thra closing when it is supposed to open. If the urethra is not strong enough to hold the urine in the bladder, the video shows it spread open, with urine leaking out. The video urodynamics equipment is very expensive, and for most women the additional information it makes available does not help to diagnose the prob­lem. Therefore, your doctor may choose not to perform this test.

In some situations, it is important to get an idea of what the blad­der, kidneys, and urethras (the tubes that bring the urine from the kidneys to the bladder) look like. While video urodynamics testing shows the bladder and the urethra well, that test does not show the kidneys or urethras at all. One way to get a look is with a procedure called an IVP. A special solution is injected into a vein in your arm and then an X ray is taken of your kidneys, urethras, and bladder. The injected solution collects in the urine as it forms in die kidneys and shows up on the X ray as the urine flows from the kidneys, down the urethras, and into the bladder. Tire X ray shows the shape and size of these organs and allows the doctor to see any abnor­malities that may be present. Blockage of the urethras or urethra, or leakage of urine from the bladder, may be identified.

As every woman who delivers a child knows, labor and delivery subject the body to forces that are not encountered in any other cir­cumstance. The muscles and nerves in the pelvis are especially af­fected. As the baby’s head comes down into die pelvis, it presses against the muscles that line the inside of die pelvis. The farther down the baby’s head goes into the pelvis, the greater is the pres­sure against these muscles and underlying nerves. After the cervix is totally dilated, the pushing phase of labor begins. The mother is usually asked to wait for a contraction to start, then hold her breath and bear down as hard as she can in order to push the baby out. This bearing down presses the baby’s head against the mother’s muscles and nerves to such an extent tiiat the normal flow of blood is cut off temporarily, until that push is over. Without a fresh sup­ply of blood, the tissues are deprived of oxygen and nutrition, mak­ing them more susceptible to damage. The pressures generated by pushing are three times as high as the tissues would normally tol­erate for any prolonged time. However, the few minutes of rest in between contractions usually lets blood flow back to the area. This fresh blood carries oxygen and nutrition to the muscles and nerves and carries carbon dioxide and waste materials away. The several minutes between contractions are normally enough for die tissue to recover.

Vaginal Mesh Lawsuit: Additional Legal Information

Vaginal Mesh Lawsuit News: Some recent studies show that the likelihood of incontinence and prolapse is lower if the mother (and her doctor) allows the nat­ural force of the uterine contractions to push the baby down the birth canal, rather than the mother pushing as hard as she can dur­ing this time. Studies show that if the voluntary pushing part of labor can be limited to less than an hour, there is a lower incidence of injury to the nerves and muscles of the pelvis. This alternative may be a safer and more natural way to deliver. Let the uterus do the work it was designed to do.

In some women these damaged muscles and ligaments re­main weak and do not heal entirely. As time goes on and the nor­mal changes of aging and weakening of the tissues takes place, incontinence may result. At present, only sophisticated and expen­sive tests such as MRI or nerve conduction studies can tell if these muscles and nerves have returned to normal. Unfortunately, there is no convenient, easy way for you or your doctor to know if these muscles are weakened and destined to lead to incontinence. Nor is there presently any remedy for nerve damage.

In fact, a few studies have shown just that. However, most women who deliver vaginally remain con­tinent, so no one is proposing that all women have cesarean sec­tions in order to avoid the possibility of later incontinence. We dearly do not understand all the factors that determine who will develop incontinence, so cesarean section is not necessary in many women with long or difficult labors. With our present understand­ing, many women would have to have cesareans in order to prevent one woman from developing incontinence. In addition, cesarean section has its own risks, including bleeding and the possible need for transfusion, the possibility of infection, and the risks of anes­thesia and surgical injury to the bladder or intestines. The pro­longed discomfort and recovery from a cesarean section at a time when the mother wants to be focused on caring for her baby are also not in anyone’s best interest.

Some studies regarding deliveries and bladder health have found a number of factors that might increase the risk of develop­ing incontinence or prolapse. These studies are based on a small sample (a relatively small number) ofwomen, and the results show somewhat differing risk factors. However, these studies do show that a large baby, a mother with small pelvic bones, a prolonged labor, a baby whose head is in the wrong position during labor, or the use of forceps can be associated with die later development of incontinence. As further research continues to shed light on fac­tors that contribute to incontinence, women shoidd consider dis­cussing potential risk factors with their obstetricians before or during labor. Multiple risk factors might convince a woman and her physician to choose a cesarean section rather than a vaginal de­livery. Interestingly, one survey found that 31 percent of female ob­stetricians would prefer a cesarean section for tiiemselves even if there were no problems with their pregnancy or labor.

In addition to the amount of fluid you drink, the kind you drink is also important. You should be aware that caffeine and alcohol act as diuretics. A diuretic forces more water out of your system than it puts in. So even a moderate amount of coffee, tea, cola, or alcohol increases the amount of urine that your bladder has to deal with, and this can lead to frequency and urgency. Caffeine, nicotine, alcohol, spicy foods, carbonated beverages, and citrus fruits contain substances that irritate the bladder lining. When these irritants collect in the bladder, they may cause the bladder muscle to have spasms that lead to frequency, urgency, and, in some cases, incontinence. A recent study found that four or more cups of brewed caffeinated coffee a day (instant coffee has less caffeine) leads to urgency in most women; for some women just too cups can create the same problem.

Our use of the term or terms Vaginal Mesh Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Vaginal Mesh Lawsuit visit our site often.

Vaginal Mesh Lawsuit

Vaginal Lawsuit Action

Vaginal Lawsuit: If women complain of incontinence it is important to check for coexistent medical conditions and optimize their treatment. For example, the onset of diabetes significantly increases urine output and many pharmaceutical agents can alter bladder function. In order to gain an accurate impression of the psychosocial morbidity associated with the patient’s condition, it is important to elucidate the restrictions it brings to everyday Life and the coping strategies adopted to deal with these restrictions. Many women complain of persistent urinary problems after pregnancy and childbirth. On closer questioning irritative bladder symptoms may have been present for several years prior to the pregnancy in those women found to have DO. However, both stress and urge incontinence may arise de novo at any time, especially after delivery.

Abdominal and pelvic examination form an essential part of the assessment of any woman who presents with urinary incontinence. If there are any symptoms that point to a possibLe neurological cause, it is important to perform a screening neuroLogical examination. The patient’s mobility and mental state affect her ability to react to her symptoms, and it may be appropriate to formally test these as part of the examination as they will influence management. Similarly, an assessment of motivation and manual dexterity is important in determining the treatment most likely to prove effective.

For more information on Vaginal Lawsuit follow us on our RSS Feeds.

Because of the close proximity of the Lower urinary and genital tracts in the female, the presence of pelvic organ prolapse can have an important bearing on urinary symptoms and their management. The grade of proLapse can be classified subjectively as mild, moderate or severe or graded according to the International Continence Society (ICS) pelvic organ prolapse quantification score (POP-Q).

A cystocele, which drags on the trigone of the bladder, may give rise to urgency and frequency as the trigone stretches and afferent fibres convey a sense of bladder fullness to the brain. Excursion of the bladder neck during coughing may lead to stress incontinence. This is often (but not exclusively) associated with anterior vaginal wall prolapse when a deficiency or abnormality in tissue collagen may be a common aetiological factor. In addition, pelvic masses, such as ovarian cysts or uterine enlargement, can cause urinary symptoms, and these conditions need to be excluded by bimanual examination. If this cannot be done with confidence, for example in the obese patient, then a transvaginal ultrasound scan should be considered.

Information from other sources on Vaginal Lawsuit

The impairment of quality of life (QoL) caused by urinary incontinence is difficult to predict using symptoms and urodynamic studies alone. In addition, individuals vary greatly in their perception of the significance of their lower urinary tract symptoms and how severely these restrict their normal psychosocial function. QoL questionnaires are therefore a useful adjunct in assessing the impact of urinary incontinence and bladder dysfunction.

This helps to emphasize the multidimensional nature of QoL and the importance of considering the patient’s own perception of her situation regarding non-health-related aspects of her life. There are many validated questionnaires available to assess QoL impairment [eg King's Health Questionnaire, Bristol Female Lower Urinary Tract Symptom Questionnaire (BFLUTS), Incontinence Impact Questionnaire (IIQ), Urogenital Distress Inventory (UDI)] due to urinary disorders. Most of these have a similar structure, consisting of a series of sections (domains) designed to gather information regarding particular aspects of health. They are particularly helpful for monitoring response to treatment.

Our use of the term or terms Vaginal Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Vaginal Lawsuit visit our site often.

Vaginal Lawsuit

Vaginal Lawsuit Message

Vaginal Lawsuit : Catheters are widely used for effective bladder drainage, either temporarily or permanently, when physiological and anatomical defects or obstruction of the lower urinary tract are present. When dealing with incontinence, all other possibilities for treatment or management must be explored following appropriate investigation. The urethral catheter is the most frequently used catheter as it can be quickly and easily inserted. Urethral catheterization is an accepted aseptic procedure and should be undertaken under the guidance of strict local hospital or community infection-control policies.

All catheters in the UK must now conform to British Standards following reports that some catheters were associated with cytotoxicity.8 Plastic or PVC and latex rubber are for short­term use only. They tend to attract surface deposits, causing encrustation and fractures within the catheter. Plastic catheters are also rigid and uncomfortable, causing bladder spasm and bypassing.9 Improvements on the latex catheter include ‘siliconizing’ the surface of the catheter producing a lubricant effect to facilitate insertion. Latex has also been coated in Teflon (polytetrafluoroethylene, PTFE) to make it more inert and to give it a smoother surface to reduce urethritis and encrustation.

For more information on Vaginal Lawsuit follow us on our RSS Feeds.

For long-term use, silicone elastomer- encapsulated (coated) latex catheters are recommended. Silicone reduces the incidence of trauma, urethritis and encrustation. Hydrogel catheters (eg Biocath, Bard) are similar to silicone catheters but they become smoother when hydrated. Catheters are measured in ‘French’ gauge (Fg) or ‘Charriere’ (Ch) units. This is the measurement of the external circumference in millimetres, which is approximately equal to three times the external diameter, depending on the catheter material. Catheters used in women should range from size 12Ch to 16Ch, with a small balloon.

Urinary tract infection is the most frequent complication with long-term indwelling catheters. Most catheter users wilL have bacteria in the urine within three days.11 Infections can be difficult to eradicate due to the growth of bacterial populations as an adherent biofilm on the catheter surface. Common pathogens, such as Escherichia coli, are eliminated from the urine but persist in the biofilm and restart the cycle of infection. The incidence of catheter blockage and bypassing in long-term catheterization is around 48% for blockage and around 37% for bypassing.13 Large catheter, detrusor spasm, blockage, debris or bladder calculus are all reasons for catheter failure. The use of a smaller catheter will help reduce the incidence of abnormal bladder contractions.

Information from other sources on Vaginal Lawsuit

One shouLd also enquire about the presence of stress incontinence, urinary tract infections and voiding difficulty. Nocturnal enuresis as a child is often associated with DO as an adult. A history of previous urological investigations, their result and any ensuing treatment, especially of incontinence surgery, is very important to note. If women complain of incontinence it is important to check for coexistent medical conditions and optimize their treatment. For example, the onset of diabetes significantly increases urine output and many pharmaceutical agents can alter bladder function. In order to gain an accurate impression of the psychosocial morbidity associated with the patient’s condition, it is important to elucidate the restrictions it brings to everyday Life and the coping strategies adopted to deal with these restrictions.

Our use of the term or terms Vaginal Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Vaginal Lawsuit visit our site often.

Vaginal Lawsuit

Vaginal Mesh Lawsuit Info

Vaginal Mesh Lawsuit Info News – 1/23/2012: Your doctor will perform the first examination for incontinence or prolapse in the same way as all gynecologic exams are done. The doctor will have you lie on your back on the examining table with your feet in stirrups. The uterus, fallopian tubes, and ovaries will be examined to make sure they feel normal. Even if you have had a hysterectomy, the doctor will perform an internal exam to make sure nothing else is pushing down on the vagina or rectum. The vagina will then be examined a bit more carefully to see if the blad­der or rectum is pushing against a weakened vaginal wall, causing a visible bulge. You will be asked to cough or bear down so that any weakness in the muscles supporting the bladder or rectum is made more apparent. The extra pressure will make weakened areas bulge further. Childbirth, gravity, menopause, aging, and heredity may all contribute to the problem of sagging or dropping of these organs.

The areas around the vagina and rectum will be touched with a Q-tip, and the doctor will record your ability to feel that touch. If you are unable to feel the Q-tip touching you, there may be a prob­lem with die nerves in the area of the bladder or rectum. In that case, you may be referred to a neurologist for further evaluation. Some neurological conditions, such as back injuries, strokes, dia­betes, and multiple sclerosis, can affect the muscles that aid blad­der function. During the first office visit, your doctor will probably ask you how often you urinate, how much liquid you drink in a day, and how often you have accidents. The answers to these questions are a good start, but a written record of these events may more speci­fically illustrate what happens with your bladder during the course of your day. This written record is called a voiding diary, or urolog. It is intended to be a one- or two-day record of how much liquid you drink, the amount and frequency of your urination, and how much leaking you have. Because a written record is better than relying on your memory, the voiding diary is a very accurate method of determining just how significant the incontinence problem is.

For more information on Vaginal Mesh Lawsuit: Info follow us on our RSS Feeds.

Some women wear pads to protect their underwear and clothes from urine leakage. Your doctor will probably ask you about this during the office visit. The size and absorbency of pads vary, as does die frequency that women change them during the day. In order to accurately measure the amount of urine you may be losing during die day, some doctors ask you to do a pad count For a day or two before your appointment, you will be asked to keep all the pads you use in a sealed plastic bag and bring them, along with one dry pad, to the doctor’s office. This is not the most pleasant task, but it does tell the doctor exactly how much urine you are losing during the day. We weigh the wet pads, then the single dry one, and calcu­late how much urine you have lost. In addition to measuring the number of pads you use during a day, the test can also calculate if whatever treatment we prescribe actually decreases the amount of urine lost.

In order for us to understand what is causing your incontinence, we sometimes need to figure out if the bladder muscle is working properly. The test for this is known as urodynamics, or UDS for short. Despite the peculiar name, this has nothing to do with jet planes or aerodynamics. The term urodynamics implies that we are able to see the bladder (uro), in action (dynamic). The muscular sac we call the bladder is supposed to stay relaxed and then com­fortably expand while it collects and stores urine made by the kid­neys. The bladder is supposed to work without any effort, or even awareness, on your part. Then, when you are ready to urinate, it should contract and force the urine out. The urodynamic study allows us to measure the way the bladder works: Does it fill up without the contractions associated with overactivity? Does it con­tract properly and at the right time? Can the bladder hold a reason­able amount of urine? Does it hold too little urine? Too much? When it contracts, does it get all the urine out?

Information from other sources on Vaginal Mesh Lawsuit Info:

UDS testing allows us to answer these questions. Some women may need to have UDS testing done, especially if the diagnosis is not clear to the doctor after the initial tests described above. UDS testing is performed in the office, takes about one hour, and is painless. Your doctor will ask you to undress from the waist down and wrap a sheet around your waist. First you will sit in a special chair that supports your back, buttocks, and legs in a comfortable position. This chair allows your doctor to tilt you back to a lying po­sition in order to perform the first part of the testing. Then, with­out your having to move, you can be tilted to a sitting position to see if your bladder functions any differently while you are up­right—as you are for most of the day. The first part of the testing involves urinating into a specialized basin that measures how fast or slowly the urine comes out of your bladder. If something is blocking the urine, such as scarring inside the urethra or a bladder muscle that isn’t working properly, the flow will be slow.

Vaginal Mesh Lawsuit Info: More information from other sources related to your search

Many doctors feel they are able to tell the kind of bladder problem you are having based upon your answers to the questions and the examination in the office. However, a recent study found this ap­proach to diagnosis much less than 100 percent accurate. The re­searchers asked a bladder specialist to look at the records of more than three hundred women who had bladder problems, with the exception of the results of urodynamic tests that were also per­formed. The specialist diagnosed one hundred women with stress incontinence based on answers to the doctor’s questions and phys­ical examination. But a careful look at the urodynamics testing showed that only thirty-eight of those women really had pure stress incontinence. The other women had either an overactive bladder or a mixture of stress incontinence and an overactive bladder.

Urodynamics testing tells us about the pressures inside the blad­der and urethra, but it does not tell us what the bladder and urethra look like when the bladder is filling or emptying. Some research centers have been testing video urodynamics equipment, which al­lows the physician to see the bladder on X ray as it fills, holds fluid and empties. By comparing this X-ray picture with the actual pres­sures recorded at the same time by the urodynamics instruments, they can get a good picture of how the bladder is actually working.

If the flow of urine out of the urethra is blocked, the video re­veals where the blockage is. If the bladder and urethra are not working properly to let the urine out, the video may show the ure­thra closing when it is supposed to open. If the urethra is not strong enough to hold the urine in the bladder, the video shows it spread open, with urine leaking out. The video urodynamics equipment is very expensive, and for most women the additional information it makes available does not help to diagnose the prob­lem. Therefore, your doctor may choose not to perform this test.

Vaginal Mesh Lawsuit Info: More news about Vaginal Mesh Lawsuit Info:

Everyone who has had a child knows that once that baby is born, life is never the same again. Women also know that their bodies are never exactly the way they were before they gave birth. Recent evidence tells us more precisely how they change. Women who have not delivered a child vaginally rarely develop incontinence or pelvic muscle relaxation, while women who have vaginal deliveries sometimes do. Again, be assured that most women will not go on to develop incontinence after childbirth. There are many factors that can lead to incontinence; the strength of the pelvic supporting structures you were bom with; the forces these structures have resisted over the years, including childbirth, heavy lifting, and straining during bowel movements; your ability to heal if these tissues are injured; the effect of the aging process on the collagen that gives strength to these struc­tures. Probably no one factor is completely responsible for the de­velopment of incontinence.

The connection between incontinence and childbirth has been assumed for a long time. When gynecologists see women for prob­lems of incontinence, they are not surprised to find severe prob­lems in women who have had many children or who have delivered large babies. Doctors have started working out the details of these relationships and are looking for the specific reasons why some women go on to develop incontinence and other women never have this problem. Although the studies are preliminary and involve only small numbers of women, details are starting to emerge.

About 10 to 20 percent of women who have a vaginal delivery will be bothered by prolapse—bulging of the bladder, rectum, or uterus into the vagina—by the time they reach the age of fifty. Women who deliver one child have a three times’ greater risk of developing prolapse than women who have not had children. Women who delivered two children have a five times’ increased risk, and women with four or more children have an eleven times’ greater likelihood of developing this problem. Women who need to push longer than one hour to deliver, or who deliver larger babies, appear to be at a greater risk of developing incontinence later in life. There is increasing evidence that childbirth is responsible for much of the injury to the muscles and nerves of the pelvis. This injury eventually leads to urinary loss and pelvic prolapse. Most women are not aware of this somewhat new information. In fact, many doctors are not apprised of the recently collected data. This chapter explains what we know, so far, about incontinence and childbirth.

Our use of the term or terms Vaginal Mesh Lawsuit Info: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Vaginal Mesh Lawsuit Info: visit our site often.

Vaginal Mesh Lawsuit